There is a sentence most clinical leaders have heard in some form: “You have excellent clinical skills, but you’ll need to develop your management thinking.” It is delivered kindly, usually with a course recommendation attached. It is also, on the evidence, backwards.
Consider what a clinician does with an undifferentiated presentation. She gathers symptoms and context, attentive to what the patient says and what they do not. She generates a differential – multiple structured hypotheses held simultaneously. She tests them through examination and investigation, discarding and refining. She implements treatment and adapts it by response, because first plans rarely survive contact with a complex human system.
Now place that alongside the process healthcare organisations pay consultancies to teach: discover, define, develop, deliver – the Double Diamond at the heart of design thinking. The mapping is not approximate. It is step for step. Clinical reasoning is design thinking practised under uncertainty, in a complex adaptive system, with higher stakes than any product studio ever faces.
This would be a pleasing observation if the evidence stopped there. It does not.
A systematic review of 19 quantitative studies found that clinical leadership improves hospital performance – across quality, safety and patient satisfaction – in 80% of cases. European health systems, where clinicians hold 50–71% of senior management positions, consistently outperform the UK and US models, where clinical backgrounds account for 22–26% of board-level roles and fewer than 4% of American hospitals are physician-led. When Virginia Mason put frontline clinicians in charge of redesigning medication administration, errors fell by 73%.
Set against that, the counterfactual. Between 2005 and 2013 the NHS rolled Lean and its derivatives across more than 150 trusts; central funding and local implementation costs together plausibly approach £1 billion. The ten-year evaluation of its flagship programme found no sustained improvement in patient outcomes, and systematic review has not established that Lean interventions deliver them. The money taught process improvement to a workforce already practising something more sophisticated daily – a simpler version of its own reasoning, sold back to it.
How did the capability become invisible? By design, and the design has a date. In 1983 the Griffiths Report – commissioned from a supermarket executive – recommended separating clinical work from management, and it was implemented nationally. The bifurcation persists in every job description, committee terms of reference and career pathway since: you are a clinician or you are a manager. Four decades on, when a clinician reasons about an organisational problem, the reasoning is heard as “the clinical perspective” – input to be weighed, rather than methodology to be followed. The most sophisticated diagnostic workforce in any industry is consulted about decisions it should be equipped to lead.
The implication is a reframing, and reframings matter because they change what you do on Monday. The deficit model says: to lead transformation, first acquire management thinking. The recognition model says: you hold the reasoning already; what you were never given is the instruments. You have a stethoscope for the body and nothing for the system. And the missing set is not the back end of the process – it is the whole of it. Ethnography, pathway mapping, stakeholder mapping and co-design do at service level what history and examination do at the bedside; financial modelling, capital planning and delivery architecture are what a boardroom case is built from.
Three moves follow.
First, translate rather than defer. When a transformation proposal reaches your committee, run it through clinical reasoning explicitly: what is the presenting complaint, what is the differential, what would falsify the preferred diagnosis, what is the plan if the first treatment fails? Name the steps as you use them. The method earns authority when it is visible.
Second, audit the exclusion. Count where clinical reasoning actually sits in your transformation governance: who chairs, who decides, who is “consulted”. Naming that gap precisely is more effective than resenting it privately.
Third, resist the training reflex. When the next methodology programme is proposed, ask two questions. What evidence supports the assumption that the reasoning is absent? And which instruments does it supply, at which end of the process? Programmes that teach the business of scaling an idea assume the right problem was framed upstream, and that assumption is almost never tested. Both questions change procurement conversations.
None of this argues that management expertise is dispensable, or that every clinician wants organisational leadership. It argues something narrower: healthcare’s transformation failures are not explained by a shortage of reasoning, because the reasoning demonstrably exists and demonstrably improves performance where it is allowed to operate. What is short is instruments and authority. Both are governance choices.
So the next time someone suggests you need to learn to think differently to lead change, there is a better answer available. The reasoning is already here. What is missing is the instrument set – the discovery methods that frame the right problem at service level, and the financial and planning instruments that let the resulting case survive a board. Acquire those and the argument stops being one you lose politely. That is the difference between a redesign that is discussed and one still standing in five years.
Author
Daniel Steenstra

Daniel Steenstra is clinically trained (VU Amsterdam), designed for 11 years at Jaguar Cars and Carrozzeria Michelotti, and taught design thinking at the University of Warwick for 25 years. He is Managing Director of InterAlign Organisation Ltd and a retired RAEng Visiting Professor at Cranfield University. X: @danielsteenstra
Declarations of Interests
Daniel Steenstra is the author of Design Thinking for Healthcare: A Practical Guide to Healthcare Transformation (Productivity Press / Routledge, 5 October 2026, with a foreword by Professor the Lord Darzi of Denham), from which this piece draws. He is Managing Director of InterAlign Organisation Ltd. No other competing interests.